首頁 › 癌症（所有類型） › 俄克拉荷馬州 › Oklahoma City
Oklahoma City, OK 的 癌症（所有類型） 臨床試驗
14 項針對 癌症（所有類型） 的研究正在 Oklahoma City（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
招募中2 期
- OU Health - Stephenson Cancer Center /ID# 277656, Oklahoma City
Registry Study for Radiation Therapy Outcomes
招募中觀察性研究
- Oklahoma Proton Center, Oklahoma City
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
招募中1/2 期
- University of Oklahoma, Oklahoma City
Prospective Study to Assess a Diagnostic Aid for Cancer
招募中觀察性研究
- Hightower Clinical, Oklahoma City
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
招募中2/3 期
- University of Oklahoma Peggy and Charles Stephenson Cancer Center, Oklahoma City
A Phase 1/1b Study of IAM1363 in HER2 Cancers
招募中1 期
- OU Health Stephenson Cancer Center, Oklahoma City
Project: Every Child for Younger Patients With Cancer
招募中觀察性研究
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
招募中3 期
- University of Oklahoma Health Sciences Center, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
招募中觀察性研究
- Mercy Hospital - OKC, Oklahoma City
GEMINI-NSCLC: NSCLC Biomarker Study
招募中觀察性研究
- Hightower Clinical, Oklahoma City
- Mercy Clinic Oncology and Hematology - Coletta, Oklahoma City
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
招募中2 期
- Oklahoma University Stephenson Cancer Center, Oklahoma City
A Study of NX-1607 in Adults With Advanced Malignancies
招募中1 期
- University of Oklahoma, Oklahoma City
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
招募中觀察性研究
- Mercy Clinic Oncology and Hematology - Coletta, Oklahoma City
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
招募中
- OUHSC Stephenson Cancer Center, Oklahoma City
- Mercy Health Center - Oncology Hematology, Oklahoma City
其他城市的 癌症（所有類型） 試驗
- Houston, TX121 項研究
- New York City, NY109 項研究
- Boston, MA85 項研究
- Los Angeles, CA74 項研究
- Nashville, TN65 項研究
- Philadelphia, PA59 項研究
- Washington, DC58 項研究
- Durham, NC58 項研究
- Chicago, IL51 項研究
- Atlanta, GA49 項研究
- Seattle, WA49 項研究
- Arlington, VA48 項研究
Oklahoma City 的其他研究
- 非小細胞肺癌28 項研究
- 卵巢癌28 項研究
- 子宮內膜癌25 項研究
- 大腸直腸癌22 項研究
- 前列腺癌21 項研究
- 肺癌19 項研究
- 乳癌17 項研究
- 轉移性癌症16 項研究
- 急性髓系白血病14 項研究
- 頭頸部鱗狀細胞癌13 項研究
- 膀胱癌11 項研究
- 胰臟癌11 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。